PillRx only · Tablet · Oral
Acarbose
Acarbose
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.186
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
6
Active US suppliers
58%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
19K
Rx · 2026 Q1
2.3M
Units dispensed
-10%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| PD-Rx Pharmaceuticals, Inc. | unknown | 12 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | unknown | 9 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 6 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 3 | SUPPLYING |
| Chartwell RX, LLC | unknown | 3 | SUPPLYING |
| Strides Pharma Science Limited | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 2, 2015RECALLRecall (Class II): Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories,…
Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point. — Recalling firm: Boehringer Ingelheim Roxane Inc — Nationwide and Puerto Rico